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a b s t r a c t
The hypoglycemic pharmaceutical glibenclamide (GLB) is widely used around the world. This medication
is released into the environment by municipal, hospital and industrial wastewater discharges. Although
there are reports of its environmental occurrence in the scientific literature, toxicity studies on aquatic
species of commercial interest such as the common carp Cyprinus carpio are scarce. The present study
aimed to evaluate the oxidative stress induced on C. carpio by environmentally relevant concentrations of
GLB. Biomarkers of oxidative damage such as hydroperoxide content, lipid peroxidation and protein
carbonyl content were evaluated as well as the activity of the antioxidant enzymes superoxide dismutase
and catalase. The concentration of GLB was determined in water as well as in gill, liver, muscle, brain and
blood of carp at 12, 24, 48, 72 and 96 h. The findings obtained in the study prove that GLB induces in-
creases in biomarkers of oxidative damage and antioxidant enzyme activity in the teleost C. carpio, that
Abbreviations: CAT, Catalase; CHP, Cumene hydroperoxide; CYP450, Cytochrome P450; EC50, Median effective concentration; GLB, Glibenclamide; HPC, Hydroperoxide
content; HPLC-MS/MS, High performance liquid chromatography-tandem mass spectrometry; LC50, Median lethal concentration; LPX, Lipid peroxidation; MDA, Malon-
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Hyperglycemic agent
Teleost
this response is not concentration dependent and that the organs evaluated bioconcentrate this hypo-
glycemic agent. These findings permit us to conclude that the presence of GLB in water bodies represents
a risk for aquatic species.
© 2018 Elsevier Ltd. All rights reserved.
1. Introduction
Type 2 diabetes mellitus is one of the metabolic disorders
currently prevalent at world level. In 2012, the International Dia-
betes Federation estimated that more than 371 million people live
with this disease and 4.8 million die from it each year. At the global
level, it is estimated that by 2030 the number of diabetic persons
will have increased to 439 million, representing 7.7% of the adult
population (aged 20e79 years) in the world (Juan et al., 2013).
The group of pharmaceuticals used to treat this ailment are oral
hypoglycemic agents. One of the more commonly prescribed of
these is glibenclamide (GLB) which is widely produced and
consumed throughout the world, it is the most common treatment
for gestational diabetes since 2007 in US and their use increased
from 7.4% to 64.5% in this country (Balsells et al., 2015; Castillo et al.,
2014) Previous studies have determined the presence of GLB in
diverse effluents: in Spain in the municipal wastewater of Rubí
(Barcelona) at concentrations of 19.2e100 ng L"1 (Radjenovic et al.,
2007; Verlicchi et al., 2012); in wastewater and sewage sludge of
Terrassa (Barcelona) at 15900 ng L"1 (Radjenovic et al., 2009); in
Río Ebro water at concentrations of 40 ng L"1 to 2000 ng L"1
(Postigo Rebollo et al., 2011); and in water treatment plants of
Catalonia at concentrations of 0.6 and 4.6 ng L"1 (Ginebreda et al.,
2012, 2015). The presence of GLB has also been detected in
reclaimed water for irrigation in Florida (US) at concentrations of
22 ng L"1 (Wang and Gardinali, 2013) and surface waters in
Portugal and Spain at 10.9e43.6 ng L"1 (Osorio et al., 2016).
As regards GLB toxicity, it has been proved to have harmful ef-
fects on humans, rodents and other animal species like DNA
damage, oxidative stress, genotoxicity and mutagenesis (Ibarra-
Costilla et al., 2010; Martínez-P!erez, 2004; Morales-Alvarado and
Murga-Valdez, 2007; Nazaroglu et al., 2009; Tüzün et al., 1999).
However, very little is known about its toxic effects on hydrobionts
common in aquatic systems or its behavior and fate in the envi-
ronment (Barcel!o et al., 2009; Gros et al., 2010; Richardson and
Terners, 2009, 2011; Santos et al., 2013).
The toxokinetics of GLB in mammals includes rapid oral ab-
sorption; GLB binds to plasma proteins in a high percentage. Also, it
is biotransformed in the liver via hydroxylation of the cyclohexyl
ring at the cis-3 and trans-4 prositions by the cytochrome P450
(CYP450) system, in which the isoforms 2C9, 2C19 and 3A4 are
involved. GLB is also biotransformed in the kidneys although this is
a minor process. This pharmaceutical is eliminated from the body
through renal and biliary excretion (Aguilar-Bryan et al., 1995;
Philipson and Steiner, 1995). Although the presence of the 2C9
isoform has not been reported in the international literature, the
same events may occur in fish.
In the phase I biotransformation of GLB, a complex called oxy-
cytochrome P450 (O2-P450-Fe2þ-GLB) is formed. This complex
breaks down, releasing the superoxide anion radical (O2!), with
regeneration of the ferric protein (P450- Fe3þ-GLB) and subsequent
formation of H2O2. The latter products, called reactive oxygen
species (ROS), are responsible for oxidative stress induction, elic-
iting damage in biomolecules such as lipids, proteins and nucleic
acids (Guengerich, 2012; Krest et al., 2013).
The regulated production of free radicals and the maintenance
of redox homeostasis are essential for the physiological health of
organisms. The generation of ROS is induced by internal and
external agents, such as phagocytes, enzymes (such as CYP450),
radiation and exogenous chemicals. In the same way, the genera-
tion of ROS can be reduced or reversed by various enzymes, called
antioxidants, such as superoxide dismutase (SOD), catalase (CAT)
and glutathione reductase (GR) (Kovacic and Jacintho, 2001). The
endogenous ROS serve as a second messenger in signal trans-
duction and are thought to be important in ion transport, immune
defense of the host, transcription and cell apoptosis (Lander, 1997;
Dennery, 2007). However, ROS can also be harmful due to their
covalent or irreversible binding to cellular macromolecules, they
are responsible for diverse effects on cells and tissues associated
with mutagenesis and carcinogenesis (Ibarra-Costilla, 2004;
Martínez-P!erez, 2004).
Oxidative stress refers to a state in which the cell is exposed to
an increasingly oxidizing environment and antioxidant defense
mechanisms are overcome, so that cellular redox status is altered;
this is considered one of the major mechanisms of action of toxic
substances due to this causes the irreversible oxidation of DNA,
proteins and lipids, which leads to the inactivation of many en-
zymes and cell death and it can also affect gene expression by
interfering with the activity of redox-sensitive transcription factors
and signal transduction by the oxidation of thiols (Martínez, 2005;
Sahambi and Hales, 2006). The oxidative damage induced on lipids,
proteins and nucleic acids, and its effects on enzymatic mecha-
nisms of antioxidant defense in living organisms have been used in
recent years as a biomarker for monitoring environmental
contamination (Dalle-Donne et al., 2003; Kadiiska et al., 2005; Lam
and Gray, 2003).
Fish toxicity studies are among the most effective methods for
understanding the harmful effects induced by environmental
contaminants in aquatic systems. Fish play a major role in aquatic
food webs, where they usually occupy an intermediate or high
position: they not only feed on a variety of aquatic predators, they
are also an important source of food for human populations around
the world (van der Oost et al., 2003).
To evaluate the toxic effects of contaminants in diverse water
bodies, test species known as bioindicators are used. The common
carp Cyprinus carpio is frequently used as a bioindicator species,
since cyprinids are one of the major groups of teleost fishes
cultured for commercial purposes throughout the world and its
members are also highly sensitive to toxic substances, show rapid
response to changes in their aquatic environment and are easy to
maintain in the laboratory (Elizalde-Velazquez et al., 2016; G!omez-
Oliv!an et al., 2014; Huang et al., 2007; Islas-Flores et al., 2013, 2014;
San Juan-Reyes et al., 2013, 2015). While some studies have shown
that GLB induces oxidative stress in mammals such as male albino
rat neonates at doses of 5mg/kg weight (Tüzün et al., 1999) and
changes in the activity of the enzymes superoxide dismutase (SOD),
catalase (CAT) and glutathione peroxidase in male Sprague Dawley
rat at the same dose (Nazaroglu et al., 2009), the scientific literature
includes no studies on the capacity of GLB to induce oxidative stress
on aquatic species of commercial interest such as common carp.
Therefore, the present study aimed to evaluate the toxicity induced
by three environmentally relevant concentrations of GLB (50, 100
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and 1000 ng L"1), which were selected based on available data of
occurrence of GLB in diverse water bodies. Brain, gill, blood, liver
and muscle of C. carpio were analyzed to evaluate oxidative stress
biomarkers such as hydroperoxide content (HPC), lipid peroxida-
tion (LPX) and protein carbonyl content (PCC), as well as the activity
of the antioxidant enzymes SOD and CAT.
2. Materials and methods
2.1. Test substance
Glibenclamide (CAS No. 10236-21-8, >99% purity) was pur-
chased from Sigma-Aldrich (Toluca, State of Mexico). A stock so-
lution was prepared with 1 g GLB in 0.02% DMSO for dilution in 1 L
distilled water. From this primary solution all other GLB concen-
trations (50, 100 and 1000 ng L"1) were prepared.
2.2. Species procurement and acclimation
Test organisms used in the study were obtained from the
common carp aquaculture center in Tiacaque (State of Mexico). In
the acute toxicity assay, one-month-old alevins of Cyprinus carpio,
2.5± 0.5 cm long and weighing 5.5± 0.5 g, were used. In the sub-
lethal toxicity assay, three-month-old juveniles, 15.5± 0.5 cm long
and weighing 57.5± 4.5 g, were used. Fish were securely placed in
sealed polyethylene bags containing two-thirdswater with 80e90%
oxygen saturation, transported to the laboratory where they were
stocked in a large 500-L tank filled with 450 L of dechlorinated tap
water previously reconstituted with salts, and acclimated for 30
days prior to the experiment. During acclimation, carp were fed
Pedregal Silver™ fish food and ¾ of the tank water was replaced
every 24 h. The physicochemical characteristics of reconstituted
water were maintained: temperature 20 ± 2 $C, oxygen concen-
tration 80e90%, pH 7.5e8.0, total alkalinity 17.8± 7.3mg L"1, total
hardness 18.7± 0.6mg L"1. A natural light/dark photoperiod was
maintained (12:12 h).
Water from the fish farm was analyzed by atomic absorption to
ensure that carp had not been exposed to other contaminants like
As, Cd, Cu, Cr, Hg, Ni, Pb and Zn. The results obtained didn't show
pharmaceuticals or other contaminants that might interfere with
the experiment.
2.3. Determination of acute toxicity (median lethal concentration,
LC50)
The procedure used to determine the LC50 was performed as
provided in Guideline 203 of the Organization for Economic
Cooperation and Development (OECD, 1992), for determination of
acute toxicity in fish exposed to chemical substances. In this assay,
five exposure systems with five different concentrations of GLB
(132, 209, 332, 526 and 834mg L"1) were used, as well as a sixth
GLB-free control system. Ten fish at the alevin stage were exposed
in each system. As stipulated in Guideline 203, the experiment was
static without medium renewal. The assay was performed in trip-
licate, using a total of 180 fish.
Test system containers (60% 40% 20-cm glass tanks) were
added the aforementioned GLB concentrations. The systems were
maintained at ambient temperature with a natural light/dark
photoperiod (12:12 h); constant aeration (80e90% oxygen con-
centration) was provided and fish were not fed during the assay.
As recommended in the OECD Guideline, the exposure timewas
96 h and test specimens were observed at 12, 24, 48, 72 and 96 h.
The principal variable evaluated in this experiment was mortality.
The 96-h LC50 of GLB and its 95% confidence limits (p< .05) were
estimated using the EPA Probit analysis program v1.5. Also, this
protocol was reviewed and approved by the Bioethics Committee of
the Universidad Autonoma del Estado de Mexico (UAEM) to ensure
that it was carried out in accordance with institutional standards
for the care of animal test subjects. Provisions set out in the official
Mexican norm on the production, care and use of laboratory ani-
mals (NOM-062-ZOO, 1999) were also taken into account.
2.4. Quantification of GLB by high performance liquid
chromatography-tandem mass spectrometry (HPLC-MS/MS)
2.4.1. Equipment and chromatographic conditions
Quantification of GLB in water and tissue samples was per-
formed using an Agilent 1100 HPLC system (Palo Alto, CA) equipped
with Agilent vacuum degasser, quaternary pump and autosampler.
Separationwas donewith Agilent LiChrospher® 100 RP-18 columns
(125mm% 4mm ID, 5 mm particle size). The injection volume was
30 mL; the flow rate was 0.7mLmin"1. Separation was made by
gradient elution using 0.1% formic acid (v/v) as solvent A and an
aqueous solution of 10mM ammonium formate [containing 0.1%
formic acid (v/v)] as solvent B. The gradient elution program was:
0e3min: 10% solvent A; 3e5min: linear increase to 50% A;
3e8min: linear increase to 90% A; 8e10min: hold at 90% A;
10e10.1min: linear decrease to 10% A; with a final hold at 10% A
until 12.0min. The column was thermostated at 25 $C.
MS was performed with an Agilent 6520 Q-TOF unit equipped
with electrospray ionization source. The settings used for GLB
ionization were: MS capillary voltage 3800 V; drying-gas flow rate
12 Lmin"1; drying-gas temperature 350 $C; nebulizer pressure 60
psi. The system operated in the high resolution mode (4 GHz). Mass
axis was calibrated over the range 70e3200 m/z using the
manufacturer-provided mixture. A sprayer with a reference solu-
tion was used for continuous calibration in positive ionization
mode using as reference masses 121.05m/z and 922.01m/z. The
optimization of spectrometer parameters for GLB was: retention
time 8.56min; precursor ion 494.15m/z; product ions 169.0027m/
z (product ion used for quantification 171.0037m/z); fragmentor
100 V; collision energy 10 eV; instrumental detection limit
0.20 ng L"1.
2.4.2. Solid phase extraction
Chromabond Tetracycline cartridges were used for solid phase
extraction of GLB from water and tissue samples. Cartridges were
conditioned with 10mL methanol, followed by 5mL HPLC-grade
water. Prior to extraction, the pH of water samples was adjusted
to 8.5 by adding 0.1M NaOH. Water samples (200mL) were
percolated through the cartridges at a flow rate of approximately
10mLmin"1. Then, each sample bottle was rinsed with 10mL
HPLC-grade water and the rinse was drawn through the cartridge.
Cartridges were washed with a further 5mL HPLC-grade water and
dried for 10min. GLB was eluted using four successive aliquots of
1mL methanol at a flow rate of approximately 1mLmin"1. The
eluates were collected in 10-mL collection tubes and evaporated at
room temperature to dryness with a gentle nitrogen stream. Then,
the extracts were reconstituted in 1mL methanol.
Gill, liver, brain and muscle samples were lyophilized, and
accelerated solid-phase extraction was employed using 1 g of
lyophilized tissue, methanol with 1% acetic acid, and sand (20e30
mesh particle size) as the dispersing agent. Fiberglass and cellulose
filters were used to retain the lipidic phase. Extraction conditions
were: 1000 psi; 25 $C; heat-up time 6min; static cycle 3% 10min;
flush volume 100%; purge time 60 s; 11mL cells contained in one
cellulose filter.
At the end of the procedure, 15mL of the sample were obtained
for subsequent analysis, under the conditions described in section
2.4.1.
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2.5. Determination of oxidative stress
Three different concentrations of GLB (50, 100 and 1000 ng L"1;
hereafter referred to as C1, C2 and C3 respectively) were used for
this assay. Exposure times were 12, 24, 48, 72 and 96 h. The
experiment comprised three exposure systems (one for each test
concentration) plus one GLB-free control system for each exposure
time. The assay was performed in triplicate. Each system contained
five fish at the juvenile stage (weight and size as described in
section 2.2.). A total of 60 systems and 300 fish were used. The GLB
concentrations used are based on relevant data of occurrence of
GLB in diverse water systems, both municipal wastewater and river
water, reported by Ginebreda et al. (2012, 2015), Postigo Rebollo
et al. (2011), Radjenovic et al. (2007, 2009), and Wang and
Gardinali (2013).
All test systems were prepared using water with the same
characteristics and conditions described in section 2.2. The con-
tainers used were 120% 80% 40-cm glass tanks. Static systems
without renewal were used. No food was provided to specimens
and tank water was not changed during the assay. At the end of
each exposure time, fishwere anesthetized and bloodwas collected
by puncture using a previously heparinized 1-mL hypodermic sy-
ringe. Puncture was made near the base of the caudal peduncle, at
mid-height of the anal fin and ventral to the lateral line.
After puncture, fish were anesthetized in a container filled with
water and 0.01% eugenol, and euthanized prior to removal of the
gills, liver, muscle and brain. Then, 1 g of each organ were placed in
phosphate buffer solution (pH 7.4), homogenized and then centri-
fuged at 12,500% g and"4 $C for 15min. Centrifuged samples were
frozen and the supernatant was used to evaluate HPC, thio-
barbituric acid reactive substances (TBARs), PCC, and SOD and CAT
activity.
2.6. Determination of HPC
HPC determinationwas based on oxidation of ferrous ions to the
ferric state due to presence of hydroperoxides under acidic condi-
tions; ferric ions bind to the xylenol orange indicator to form a
stable colored complex which is read at 560 nm, according to the
method described by Jiang et al. (1992). First, 0.1mL of supernatant
was mixed with 0.9mL reaction solution (0.25mM FeSO4, 25mM
H2SO4, 0.1mM xylenol orange and 4mM butylhydroxytoluene in
90% methanol v/v). The mixture was incubated for 60min at
ambient temperature while light protected, after which, absor-
bance was read at 560 nm against a blank subjected to the same
conditions but using distilled water instead of supernatant. HPC
content was estimated using the molar extinction coefficient (MEC)
of 4.3% 104M"1 cm"1 and results were expressed as nM cumene
hydroperoxide (CHP) mg"1 protein wet weight.
2.7. TBARs assay
Malondialdehyde (MDA) content was analyzed as TBARs by the
spectrophotometric method described by Büege and Aust (1978).
This procedure involved mixing 0.05mL of supernatant and
0.45mL Tris-HCl buffer solution (150mM, pH 7.4). Next, 1mL TBA-
TCA reagent (0.375% thiobarbituric acid in 15% trichloroacetic acid)
was added. The resulting solutionwas Vortex-shaken for 1min, and
samples thus prepared were immersed in a boiling water bath for
15min, then immediately cooled at "5 $C for 3min. Samples were
later incubated for 30min at 37 $C, then centrifuged at 3500% g for
10min. Absorbance was read at 535 nm using a blank subjected to
the same treatment as samples, and distilled water instead of su-
pernatant. Results were expressed as nM MDA, using the MEC of
1.56% 105M"1 cm"1 to calculate MDA content.
2.8. Determination of PCC
PCC was determined by the method described in Levine et al.
(1994), as modified by Parvez and Raisuddin (2005) and Burcham
(2007). In this analysis, supernatant (0.2mL) was mixed with
0.15mL 2,4-Dinitrophenylhydrazine (DNPH,10mM in 2MHCl). The
mixture was incubated for 60min at room temperature while light
protected, then supplemented with 0.5mL of 20% TCA and centri-
fuged for 5min at 11,000% g. The resulting precipitate was
collected and washed several times with 1:1 ethyl acetate:ethanol.
Next, the bud was dissolved in a 1mL guanidine solution (6M, pH
2.3) and incubated at 37 $C for 30min, then absorbance was read at
366 nm. Results were expressed as nM reactive carbonyls (C¼O)mg
protein wet tissue"1, using the MEC of 21,000M"1 cm"1.
2.9. Determination of SOD activity
SOD activity was analyzed by the method of Marklund and
Marklund (1974) as modified by Magnani et al. (2000). The super-
natant was previously delipidized by adding 0.03mL chloroform
and 0.05mL methanol, then Vortex-shaken for 1min and centri-
fuged at 6000% g for 15min. Next, to 0.1mL of delipidized super-
natant was added 2.8mL Tris-EDTA buffer solution, pH 8.2. The
resulting mixture was shaken in the Vortex for 1min, and was then
added 0.05mL of a 0.2mM pyrogallol solution. The difference be-
tween optical density (OD) at 10 and 60 s, at 420 nm wavelength
was determined. After this, the percentage of inhibition of pyro-
gallol autoxidation was obtained by dividing the difference in test
sample ODs by the difference in control sample ODs and multi-
plying by 100. Results were expressed as IU SOD mg protein wet
tissue"1; to this end the quotient of the percentage of pyrogallol
autooxidation was divided by 50%, since 1 IU SOD induces a 50%
inhibition of pyrogallol autooxidation at 25 $C.
2.10. Determination of CAT activity
CAT activity was estimated by the Radi et al. (1991) method,
which is based on evaluating enzyme activity when H2O2 is
reduced in a medium prepared by mixing 1mL isolation buffer
solution (0.3M sucrose, 1mM EDTA, 5mM HEPES and 5mM
KH2PO4) with 0.02mL of supernatant, and supplementing with
0.2mL of 20mMH2O2. The CATactivity required to reduce the H2O2
substrate was measured at 0 and 60 s, at 240 nm, and was
expressed as mM H2O2 mg protein wet tissue"1. Values were
calculated by substituting absorbance readings in the formula: CAT
concentration ¼ (A0 e A60)/MEC, where the MEC of H2O2 is
0.043mM"1 cm"1. Results were expressed as units mg protein"1; 1
unit is defined as the quantity of enzyme required to break down
1 mmol H2O2 min"1 at 25 $C and pH 7.0.
2.11. Determination of total protein content
Total protein content was determined by the spectrophoto-
metric method described by Bradford (1976), in which 0.025mL of
supernatant is mixed with 0.075mL deionized water and 2.5mL
Bradford reagent. This mixture was homogenized in a Vortex for
1min and incubated for 5min at room temperature while light
protected, after which, absorbance was read at 595 nm. Absorbance
readings were interpolated on a bovine serum albumin type curve
and total protein content was expressed as mg protein wet tissue.
2.12. Statistical analysis
Oxidative stress results were statistically analyzed by one-way
analysis of variance (ANOVA), and differences between means
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were compared using the Bonferroni multiple comparisons test,
with p set at <0.05. SPSS v9 software (SPSS, Chicago, IL) was used.
Pearson's correlation analysis was performed to find potential
correlations between GLB concentrations in the organs evaluated,
and the oxidative stress biomarkers used. To this end, Sigmastat
v2.03 software was used.
3. Results
3.1. 96-h LC50
The 96-h LC50 of GLB in alevins of C. carpiowas 509mg L"1, with
a 95% confidence interval of 505.96e512.16mg L"1 (p< .05). The Х2
linear adjustment test was not significant at p< .05.
3.2. Quantification of GLB in water and tissue samples
Table 1 lists GLB concentration at the different exposure times in
exposure systemwater and in the organs evaluated. As can be seen,
beginning at 12 h, GLB concentration in water decreased in all
exposure systems and increased gradually over time in all organs.
GLB bioaccumulation was highest in blood, liver and muscle, and
increased with time. Brain and gill were the organs of lowest bio-
accumulation of GLB, although concentrations also increased in
these organs with increasing exposure.
3.3. HPC
HPC results are shown in Fig. 1. At the C3 concentration
(1000 ng L"1), significant increases relative to the control group
(p< .05) occurred from 24 to 96 h in brain (254% for 24 h, 207% for
48 h, 214% for 72 h and 119% for 96 h); from 12 to 96 h in blood
(418% for 12 h, 614% for 24 h, 704% for 48 h, 669% for 72 h and 884%
for 96 h) as well as liver (55% for 12 h, 94% for 24 h, 68% for 48 h,
66% for 72 h and 51% for 96 h); at 24 and 96 h in gill (37% for 24 h
and 54% for 96 h); and from 12 to 96 h in muscle (368% for 12 h,
736% for 24 h, 734% for 48 h, 928% for 72 h and 803% for 96 h). At the
C2 concentration (100 ng L"1), significant increases were found
from 12 to 96 h in blood (318% for 12 h, 314% for 24 h, 585% for 48 h,
598 for 72 h and 762% for 96 h) as well as liver (38% for 12 h, 46% for
24 h, 29% for 48 h, 32% for 72 h and 52% for 96 h); from 12 to 48 h in
gill (26% for 12 h, 28% for 24 h and 26% for 48 h); from 24 to 96 h in
brain (128% for 24 h, 84% for 48 h, 95% for 72 h and 115% for 96 h);
and from 12 to 96 h inmuscle (301% for 12 h, 450% for 24 h, 451% for
48 h, 436% for 72 h and 324% for 96 h). At the lowest concentration
(C1, 50 ng L"1), significant differences were observed only from 12
to 96 h in blood (318% for 12 h, 314% for 24 h, 585% for 48 h, 598% for
72 h and 762% for 96 h) as well as muscle (124% for 12 h, 379% for
24 h, 380% for 48 h, 394% for 72 h and 319% for 96 h).
3.4. TBARs assay
The MDA content induced by GLB is shown in Fig. 2. At the
highest concentration (C3), significant increases with respect to the
control group (p< .05) were observed from 12 to 96 h in blood (198,
315, 268, 211 and 171%), liver (148, 186, 195, 143 and 129%) and gill
(312, 471, 437, 294 and 302%); from 72 to 96 h in brain (112 and
87%); and from 12 to 96 h in muscle (1391, 1621, 1309, 1334 and
850%). At the C2 concentration, significant increases were recorded
from 12 to 96 h in blood (88,169,172,177 and 111%); from 12 to 72 h
in liver (150, 185,167 and 92%); from 12 to 96 h in gill (137, 617, 409,
336 and 310%); from 72 to 96 h in brain (53 and 50%); and from 12
to 96 h in muscle (696, 835, 1223, 966 and 591%). At the lowest
concentration (C1), significant differences were found from 24 to
48 h in blood (47 and 40%); from 48 to 96 h in liver (134, 145 and
147%); from 12 to 96 h in gill (103, 219, 141, 110 and 153%); from 72
to 96 h in brain (96 and 103%); and from 24 to 96 h in muscle (99,
346, 727 and 631%).
3.5. PCC
Fig. 3 shows PCC results. Significant increases with respect to the
control group (p< .05) were observed at the C3 concentration from
12 to 96 h in blood (119, 108, 116, 100 and 119%); from 12 to 48 h in
liver (47, 73 and 54%) as well as gill (47, 75 and 57%); and from 12 to
96 h in brain (233, 308, 322, 304 and 347%) and muscle (141, 231,
249, 401 and 675%). At the C2 concentration, significant increases
were found from 12 to 96 h in brain (156, 218,141, 216 and 299%) as
well asmuscle (111, 269, 234, 317 and 401%); and from 12 to 48 h in
blood (67, 30 and 50%), liver (41, 49 and 30%) and gill (34, 75 and
26%). At the C1 concentration, significant increases occurred from
12 to 24 h in blood (28 and 24%) and liver (30 and 31%); from 24 to
48 h in gill (75 and 26%); from 24 to 96 h in brain (94, 212, 214 and
165%); and from 48 h to 96 h in muscle (90, 132 and 180%).
3.6. SOD activity
Results of SOD activity are shown in Fig. 4. Significant increases
relative to the control group (p< .05) were observed at the C3
concentration from 24 to 72 h in blood (250, 90 and 37%); from 12
to 72 h in liver (194, 337, 310, 108 and 154%); from 12 to 48 h in gill
(36, 55 and 59%) as well as brain (136, 114 and 73%); and from 12 to
96 h in muscle (399, 484, 505, 573 and 526%). At the C2 concen-
tration, significant increases occurred from 12 to 72 h in blood (42,
169, 38 and 71%), liver (184, 302, 320 and 145%) and gill (52, 55, 38
and 44%); from 12 to 48 h in brain (68, 80 and 95%); and from 12 to
96 h in muscle (399, 484, 505, 537 and 526%). At the C1 concen-
tration, significant increases were found from 12 to 48 h in blood
(79, 147 and 118%); from 12 to 72 h in liver (95, 253, 357 and 232%);
from 12 to 24 h in gill (57 and 31%); from 24 to 72 h in brain (51,185
and 241%); and from 12 to 96 h in muscle (114, 159, 160, 1154 and
837%).
3.7. CAT activity
Fig. 5 shows the results of CAT antioxidant activity. Significant
increases relative to the control group (p< .05) occurred at the C3
concentration from 12 to 96 h in blood (199, 393, 481, 278 and 11%)
as well as in liver, with even higher increases (404, 614, 738, 1144
and 446%), and also in gill (81, 92, 228, 343 and 103%), brain (264,
303, 675, 557 and 569%) andmuscle (69, 279, 204,122 and 119%). At
the C2 concentration, significant increases were observed from 12
to 72 h in blood (154, 196, 253 and 49%) and liver (181, 259, 345 and
127%); from 24 to 72 h in gill (56, 135 and 319%); from 12 to 96 h in
brain (248, 237, 147, 348 and 472%); and from 24 to 72 h in muscle
(177, 78 and 84%). At the C1 concentration, significant increases
occurred from 24 to 72 h in blood (27, 24 and 26%); from 24 to 48 h
in liver (83 and 100%); from 24 to 72 h in gill (49, 74 and 100%);
from 24 to 96 h in brain (116, 83, 197 and 347%); and from 24 to
48 h in muscle (35 and 45%).
3.8. Pearson's correlation analysis
Table 2 shows the correlations found between oxidative stress
biomarkers, exposure times and GLB bioconcentration in organs.
Values in bold indicate a closer correlation between analyzed
variables.
Table 3 shows the bioconcentration values obtained from the
ratio of the GLB concentration of each tissue between the concen-
tration in water.
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4. Discussion
The present study is relevant and innovative due to the fact that
the hypoglycemic agent GLB is widely used around the world and is
released into the environment through municipal, hospital and
industrial discharges. While the scientific literature includes
studies on the occurrence of this pharmaceutical in the environ-
ment, there are very few studies regarding its toxicity. Existing ones
have been conducted only on certain fish species as well as the
crustacean Daphnia magna, and are aimed at determining the acute
toxicity of this compound through LC50 determination. Therefore,
the toxic effects induced by GLB on other fish species of commercial
interest, such as C. carpio, need to be characterized using bio-
markers that provide information on how this compound damages
biomolecules such as proteins, lipids and nucleic acids. Results
obtained in the present study determine that GLB is toxic. Although
its LC50 values are high in comparison to other emerging contam-
inants, our study proves that concentrations of ng L"1 can induce
lipid and protein oxidation as well as oxidative stress.
The LC50 of GLB was determined to be> 500mg L"1
(505.96e512.16mg L"1) in our study. The pertinent OECD docu-
ment on testing and assessment (OECD, 2001) ranks substances
with an LC50> 100mg/L as category IV, which implies that GLB is
not toxic to C. carpio.
Comparison of the LC50 of GLB in C. carpio and other species
reveals that the common carp is a more resistant species. The safety
data sheet issued in accordancewith (EC) Regulation No.1907/2006
as amended by (EC) No. 1272/2008 of the European Commission
(06, 2013) states that the LC50 of GLB in D. magna and in fish
is> 100mg L"1. Also, Cunningham et al. (2006) reported low GLB-
Table 1
Glibenclamide concentrations in exposure system water and evaluated organs.
Test concentration Exposure time (h) Water Blood Liver Gill Brain Muscle
50 ng L"1 (C1) 12 38± 1.2 3.6± 0.8 2.8± 0.6 1.6± 0.4 0.9± 0.1 2.6± 0.5
24 35± 1.3 3.8± 0.7 3.0± 0.7 2.1± 0.6 1.0± 0.2 2.8± 0.4
48 31± 1.8 4.0± 0.8 3.2± 0.6 2.4± 0.7 1.4± 0.3 3.2± 0.6
72 27± 1.1 4.8± 0.6 3.5± 0.8 2.8± 0.6 1.7± 0.6 3.5± 0.7
96 20± 1.5 5.0± 0.7 3.8± 0.6 3.2± 0.5 2.1± 0.7 3.8± 0.6
100 ng L"1 (C2) 12 75± 1.8 5.2± 1.1 4.1± 1.1 3.8± 0.8 2.6± 0.7 4.2± 0.8
24 70± 2.1 5.7± 1.3 4.4± 0.9 4.1± 0.9 3.2± 0.6 4.6± 0.7
48 66± 1.3 6.2± 0.9 4.9± 0.8 4.5± 0.8 3.8± 0.9 4.8± 0.8
72 52± 1.6 6.8± 1.2 5.3± 1.2 5.1± 0.9 4.1± 1.1 5.2± 0.9
96 49± 2.1 7.1± 0.9 6.1± 1.0 5.8± 1.0 4.6± 0.9 6.1± 1.1
1000 ng L"1 (C3) 12 770± 3.8 45± 1.1 32± 2.1 26± 1.2 19± 1.1 29± 0.9
24 623± 2.8 53± 2.3 37± 1.3 32± 1.0 23± 1.6 33± 1.1
48 556± 3.1 59± 1.8 41± 1.6 38± 1.3 29± 2.1 38± 1.4
72 447± 1.8 64± 1.7 47± 1.9 44± 1.6 31± 1.7 41± 1.0
96 382± 2.1 69± 1.7 51± 1.5 47± 2.1 39± 1.8 47± 0.9
Fig. 1. Hydroperoxide content (HPC) in blood, liver, gill, brain and muscle of C. carpio exposed to three different concentrations of glibenclamide (C1, C2 and C3) for 12, 24, 48, 72 and
96 h. Values are the mean of three replicates ± SE. CHP ¼ cumene hydroperoxide. Significant differences relative to: * control group; a 12 h; b 24; c 48 h; d 72 h; e 96 h; ANOVA and
Bonferroni (p< .05).
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induced ecotoxicity; they found median effective concentration
(EC50) values> 100mg L"1 in diverse species including daphnids,
algae and fish. Fishmortality in the present studymay be due to the
fact that excess GLB induces a hypoglycemic state in fish, altering
ion homeostasis. The latter process induces cell membrane depo-
larization and massive release of brain neurotransmitters in carp,
Fig. 2. Lipid peroxidation (LPX) in blood, liver gill, brain and muscle of C. carpio exposed to three different concentrations of glibenclamide (C1, C2 and C3) for 12, 24, 48, 72 and 96 h.
Values are the mean of three replicates ± SE. MDA ¼ malondialdehyde. Significant differences relative to: * control group; a 12 h; b 24; c 48 h; d 72 h; e 96 h; ANOVA and Bonferroni
(p< .05).
Fig. 3. Protein carbonyl content (PCC) in blood, liver, gill, brain and muscle of C. carpio exposed to three different concentrations of glibenclamide (C1, C2 and C3) for 12, 24, 48, 72
and 96 h. Values are the mean of three replicates ± SE. Significant differences relative to: * control group; a 12 h; b 24; c 48 h; d 72 h; e 96 h; ANOVA and Bonferroni (p < .05).
E.M. Guadalupe Martínez-Viveros et al. / Chemosphere 197 (2018) 105e116 111
including glutamate (Erecinska and Silver, 1989; Siesjo, 1988).
Glutamate accumulation leads to an increase in mitochondrial
calcium levels and ROS (Choi, 1987; Coyle and Puttfarcken, 1993)
which induces oxidative stress. This contributes to occurrence of
cerebral ischemia and hypoxia which inhibit the electron transport
chain with loss of mitochondrial membrane potential and subse-
quent inhibition of ATP synthesis (Siesjo et al., 1995). The latter
series of events may have contributed to fish mortality in our study.
Fig. 4. Superoxide dismutase (SOD) activity in blood, liver, gill, brain and muscle of C. carpio exposed to three different concentrations of glibenclamide (C1, C2 and C3) for 12, 24, 48,
72 and 96 h. Values are the mean of three replicates ± SE. Significant differences relative to: * control group; a 12 h; b 24; c 48 h; d 72 h; e 96 h; ANOVA and Bonferroni (p< .05).
Fig. 5. Catalase (CAT) activity in blood, liver, gill, brain and muscle of C. carpio exposed to three different concentrations of glibenclamide (C1, C2 and C3) for 12, 24, 48, 72 and 96 h.
Values are the mean of three replicates ± SE. Significant differences relative to: * control group; a 12 h; b 24; c 48 h; d 72 h; e 96 h; ANOVA and Bonferroni (p< .05).
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Table 2
Pearson's correlation analysis of glibenclamide concentration in evaluated organs and oxidative stress biomarker results.
Biomarkers Organs Time (h) Concentration Biomarkers Organs Time (h) Concentration
50 ng L"1 100 ng L"1 1000 ng L"1 50 ng L"1 100 ng L"1 1000 ng L"1
OXIDATIVE DAMAGE
HPX BLOOD 12 0.801 "0.295 0.999 LPX BLOOD 12 ¡0.564 0.462 0.644
24 0.347 "0.364 0.333 24 ¡0.992 0.992 0.928
48 ¡0.985 ¡0.740 0.788 48 "0.289 ¡0.891 "0.123
72 0.109 ¡0.683 ¡0.687 72 ¡0.739 0.794 ¡0.821
96 0.645 0.235 ¡0.980 96 0.099 0.090 0.127
LIVER 12 ¡0.774 ¡0.990 0.998 LIVER 12 0.165 ¡0.854 ¡0.554
24 0.793 0.226 0.914 24 0.987 0.333 "0.059
48 "0.148 ¡0.860 0.887 48 0.961 "0.421 ¡0.925
72 0.012 0.510 0.573 72 "0.218 "0.319 ¡0.725
96 ¡0.905 ¡0.650 0.981 96 0.592 0.618 ¡0.823
GILL 12 0.194 "0.371 ¡0.678 GILL 12 "0.192 "0.232 0.956
24 0.837 ¡0.770 0.994 24 "0.268 0.832 0.970
48 0.003 ¡0.763 "0.420 48 0.844 "0.279 ¡0.815
72 0.908 ¡0.723 0.994 72 "0.467 0.883 ¡0.867
96 ¡0.999 0.022 ¡0.887 96 0.534 ¡0.558 ¡0.998
BRAIN 12 0.998 0.847 0.989 BRAIN 12 ¡0.996 0.043 ¡0.559
24 0.095 ¡0.742 0.472 24 0.924 "0.364 "0.466
48 "0.130 0.189 0.578 48 ¡0.837 ¡0.613 ¡0.551
72 ¡0.997 0.718 "0.157 72 0.562 0.769 "0.347
96 0.235 0.616 0.287 96 ¡0.746 0.968 ¡0.999
MUSCLE 12 0.965 0.135 ¡0.998 MUSCLE 12 0.435 "0.429 0.200
24 0.765 0.092 "0.267 24 0.981 0.391 ¡0.984
48 ¡0.822 0.778 "0.165 48 "0.338 0.512 ¡0.996
72 0.459 "0.464 0.981 72 0.829 ¡0.928 0.931
96 ¡0.717 0.690 0.314 96 ¡0.980 ¡0.640 0.661
PCC BLOOD 12 "0.333 ¡0.996 "0.459
24 ¡0.951 0.583 0.214
48 0.811 0.991 0.896
72 0.123 0.928 "0.248
96 0.973 "0.122 0.093
LIVER 12 ¡0.693 "0.354 0.998
24 "0.430 0.186 ¡0.987
48 0.735 0.857 "0.360
72 0.800 "0.137 0.879
96 ¡0.813 ¡0.903 ¡0.979
GILL 12 0.357 0.108 0.675
24 ¡0.662 ¡0.999 0.778
48 0.769 0.273 ¡0.936
72 "0.004 ¡0.660 "0.200
96 ¡0.580 ¡0.994 0.925
BRAIN 12 0.781 0.215 0.913
24 ¡0.961 ¡0.982 ¡0.585
48 0.778 ¡0.746 ¡0.813
72 0.917 ¡0.732 ¡0.959
96 0.184 0.160 "0.083
MUSCLE 12 ¡0.883 ¡0.637 0.993
24 0.733 0.951 0.828
48 0.945 0.658 0.619
72 0.217 0.644 0.986
96 "0.320 ¡0.786 ¡0.959
ANTIOXIDANT ACTIVITY
SOD BLOOD 12 ¡0.641 ¡0.787 ¡0.813 CAT BLOOD 12 "0.402 0.348 0.772
24 0.215 ¡0.999 0.989 24 "0.102 ¡0.544 "0.263
48 0.992 0.980 ¡0.713 48 "0.223 0.993 0.992
72 0.647 ¡0.514 0.518 72 0.528 0.821 ¡0.974
96 "0.496 ¡0.980 ¡0.671 96 0.348 0.433 0.032
LIVER 12 ¡0.811 ¡0.609 0.990 LIVER 12 ¡0.990 0.784 ¡0.771
24 0.736 ¡0.999 ¡0.936 24 0.908 ¡0.770 ¡0.997
48 0.756 ¡0.947 ¡0.850 48 ¡0.991 ¡0.940 0.566
72 ¡0.724 0.854 0.963 72 0.125 0.044 0.295
96 0.987 ¡0.962 ¡0.983 96 0.982 ¡1.000 "0.089
GILL 12 ¡0.987 0.631 ¡0.981 GILL 12 0.529 0.834 ¡0.505
24 0.242 0.947 0.693 24 0.526 0.173 ¡0.906
48 0.302 ¡0.765 0.949 48 0.706 ¡0.998 0.801
72 0.592 0.998 0.128 72 0.496 "0.089 0.999
96 0.901 ¡1.000 0.794 96 0.690 "0.353 0.980
BRAIN 12 ¡0.971 0.974 0.983 BRAIN 12 0.976 0.766 0.968
24 0.966 ¡0.840 0.816 24 0.725 ¡0.987 0.731
48 ¡0.827 ¡0.904 0.622 48 0.700 ¡0.773 0.915
72 0.109 0.447 ¡0.825 72 0.496 ¡0.890 "0.397
96 "0.101 ¡0.860 ¡0.928 96 ¡0.881 0.011 "0.259
(continued on next page)
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The results of biomarkers of oxidative damage show increases in
HPC and TBARS (Figs. 1 and 2) in all organs evaluated at all three
test concentrations which are in themain significant. HPC increases
in blood, gill and muscle were concentration dependent, while
TBARS had a tendency to increase significantly at the highest (C3)
concentration. The greatest increase in both biomarkers occurred in
brain. Diverse factors are known to favor a high susceptibility of the
central nervous system to oxidative stress: (1) brain tissue un-
dergoes high oxidative phosphorylation and uses large amounts of
oxygen; (2) it is also rich in polyunsaturated fatty acids that can be a
substrate of lipid peroxidation; and (3) certain brain regions
contain high concentrations of free ironwhich facilitate free radical
formation (Olanow, 1993). Our results are similar to the findings of
Tüzün et al. (1999), who reported significant increases in MDA
levels in brain, liver and kidney of male albino rat neonates. HPC
andMDA increasesmay be explained by themechanism of action of
GLB: in binding to its biological receptor in the cell membrane, this
sulfonylurea elicits closing of Naþ/K þ -pump potassium channels
which reduces the efflux of postassium, inducing cell membrane
depolarization, inhibition of ATP synthesis and increased intracel-
lular calcium (Eliasson et al., 1996). This has been associated with
higher levels of extracellular glutamate (Ferrand-Drake et al., 1999)
and activation of a great variety of calcium-dependent enzymes,
the most important of these being proteases, lipases and endonu-
cleases which damage the cytoskeleton, cell membrane, and
nucleic acids respectively in the brain (Orrenius et al., 1989).
Similarly, increased intracellular calcium has been correlated with
free radical formation through activation of phospholipase A2 and
nitric oxide synthase (NOS) (Lafon-Cazal et al., 1993). Increases in
HPC and MDA can also be explained by the phase I biotransfor-
mation of GLB mediated by the CYP450 systemwhich can generate
free radicals such as hydroxyl radicals, singlet oxygen and super-
oxide. These ROS are highly reactive and can directly attack mem-
brane lipids. The subfamily CYP2 is especially responsible for GLB
biotransformation, in particular CYP2C9 (Blanco et al., 2005; Zanger
et al., 2008). Diverse CYP gene families have been characterized in
fish such as C. carpio, among others, CYP1, CYP2, CYP3, CYP4, CYP11,
CYP17 and CYP19 (Stegeman and Livingstone, 1998; Botello et al.,
2005). This suggests that the phase I biotransformation of GLB to
3- and 4-hydroxy-GLB may be similar to the process in mammals,
yielding ROS that induce increases in these biomarkers in the or-
gans evaluated. The gills are the first fish organs that enter in direct
contact with the environment; they are also the site of acid-base
regulation and the exchange of ions such as oxygen, and are able
to biotransform xenobiotics (Monteiro et al., 2005). Similarly, the
liver is the primary organ responsible for the biotransformation of
xenobiotics such as GLB (Groop et al., 1991). Thus, since oxidative
biotransformation of GLB occurs in these organs, this may explain
the ROS increases and subsequent HPC and LPX increases recorded
in gill and liver in our study.
Antioxidant enzyme results show increases in SOD activity
(Fig. 4) at all test concentrations and exposure times in blood, liver
andmuscle. The same behavior was observed in gill and brain up to
72 h. As regards CAT activity (Fig. 5), increases were found at all
concentrations and exposure times in all organs evaluated, but
particularly in brain where this effect was concentration depen-
dent. These results are consistent with those of Elmali et al. (2004)
and Tüzün et al. (1999), who found increased SOD and CAT activity
due to GLB exposure in male albino rat and male albino rat neo-
nates respectively. The antioxidant defense system is mediated by
SOD and CAT which act by scavenging ROS and converting them
into less reactive and less toxic compounds. SOD is the first enzyme
involved in this process and the one responsible for dismutation of
the superoxide anion radical to form hydrogen peroxide (van der
Oost et al., 2003). Subsequently, CAT acts on this substrate,
yielding H2O and O2 (Vendemiale et al., 1999). Increases in SOD and
CAT in the present study can be explained by the biotransformation
of GLB and the mechanism of action of this compound which, as
stated previously, induce formation of free radicals such as super-
oxide and H2O2 that are substrates of SOD and CAT respectively. On
the other hand, the results found are similar to other pharmaceu-
ticals previously reported, such as diclofenac (Islas-Flores et al.,
2013) and ibuprofen (Islas-Flores et al., 2017).
GLB concentrations in the organs evaluated at the various
exposure times indicate that the matrices in which GLB uptake was
highest were blood, liver and muscle, while the organs of lowest
uptake were gill and brain. The physicochemical properties of GLB
make this compound poorly soluble in water (approximately
38 mmol/L at 37 $C) and with low oral bioavailability (Censi et al.,
2016), which is confirmed in Tables 1 and 3 by its low bio-
concentration values in the different organs. However, these low
levels of GLB uptake induced oxidative stress at the various expo-
sure times in a statistically significant manner. In the other hand, all
biomarkers used were found to be correlated with the various test
concentrations, suggesting the presence of oxidative stress in the
organs evaluated (Table 2).
To summarize and based on our findings, GLB is suggested to
induce oxidative stress in C. carpio through the following mecha-
nism (Fig. 6): GLB binds to its biological receptor in the cell
Table 2 (continued )
Biomarkers Organs Time (h) Concentration Biomarkers Organs Time (h) Concentration
50 ng L"1 100 ng L"1 1000 ng L"1 50 ng L"1 100 ng L"1 1000 ng L"1
MUSCLE 12 1.000 0.252 "0.404 MUSCLE 12 0.888 "0.435 ¡0.646
24 ¡0.975 ¡0.783 ¡0.897 24 ¡0.933 ¡0.812 0.744
48 "0.438 0.241 ¡1.000 48 ¡0.958 0.613 ¡1.000
72 ¡0.767 0.241 0.710 72 ¡0.526 ¡0.780 ¡0.534
96 ¡0.907 "0.186 "0.003 96 ¡0.966 0.246 0.497
Correlation coefficients> 0.5 are significant (shown in bold).
Table 3
Bioaccumulation factors estimated.
Test concentration Exposure time (h) Blood Liver Gill Brain Muscle
50 ng L"1 (C1) 12 0.09 0.07 0.04 0.02 0.07
24 0.11 0.09 0.06 0.03 0.08
48 0.13 0.10 0.08 0.05 0.10
72 0.18 0.13 0.10 0.06 0.13
96 0.25 0.19 0.16 0.11 0.19
100 ng L"1 (C2) 12 0.07 0.05 0.05 0.03 0.06
24 0.08 0.06 0.06 0.05 0.07
48 0.09 0.07 0.07 0.06 0.07
72 0.13 0.10 0.10 0.08 0.10
96 0.14 0.12 0.12 tr 0.12
1000 ng L"1 (C3) 12 0.06 0.04 0.03 0.02 0.04
24 0.09 0.06 0.05 0.04 0.05
48 0.11 0.07 0.07 0.05 0.07
72 0.14 0.11 0.10 0.07 0.09
96 0.18 0.13 0.12 0.10 0.12
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membrane. As a consequence, closing of Naþ/K þ -pump-depen-
dent potassium channels takes place and potassium efflux is
reduced, leading to cell membrane depolarization. This depolari-
zationmay lead, on the one hand, to increased intracellular calcium
which activates phospholipase A2 and NOS to form free radicals,
and on the other may induce, in the brain especifically, the release
of neurotransmitters such as glutamate which, when accumulated,
also favors increased intracellular calcium, activating calcium-
dependent enzymes such as proteases, lipases and endonucleases
that can in turn release free radicals. A further way in which free
radicals are released is through the phase I biotransformation of
GLB mediated by the CYP450 system which can originate free
radical formation. Finally, these free radicals can damage the
cytoskeleton, cell membrane and DNA. Oxidative stress was
induced from the lowest concentrations (50 and 100 ng L"1) which
are environmentally relevant, so the presence of GLB in water
bodies could represent a risk for the species that are in contact with
this.
5. Conclusions
C. carpio bioconcentrates GLB from 12 h of exposure onward,
and the organs in which this compound bioconcentrates most are
blood, liver and muscle. GLB induced increases in HPC, LPX and PCC
as well as SOD and CAT antioxidant activity in all organs evaluated.
While the brain was one of the organs with lower GLB bio-
concentration, significant increases were nevertheless observed in
biomarkers of oxidative damage. The biomarkers of exposure and
effect employed in the study are reliable for use in evaluating the
impact of the sulfonylurea GLB in fish of commercial interest such
as C. carpio.
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